Pronounced Reduction Of Postprandial Glucagon By Lixisenatide: A Meta-Analysis Of Randomized Clinical Trials.

Research output: Contribution to journalArticle

Abstract

Glucagon-like peptide-1 (GLP-1) receptor agonists improve islet function and delay gastric emptying in patients with type 2 diabetes mellitus (T2DM). This meta-analysis aimed to investigate the effects of the once-daily prandial GLP-1 receptor agonist lixisenatide on postprandial plasma glucose (PPG), glucagon and insulin levels.

Details

Authors
  • Bo Ahrén
  • Jean-Francois Gautier
  • Rachele Berria
  • William Stager
  • Ronnie Aronson
  • Cliff J Bailey
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Endocrinology and Diabetes
Original languageEnglish
Pages (from-to)861-868
JournalDiabetes, Obesity and Metabolism
Volume16
Issue number9
Publication statusPublished - 2014
Publication categoryResearch
Peer-reviewedYes